5-羟甲基胞嘧啶表达与黑素瘤侵袭、转移、预后的相关性分析

doi:10.3760/cma.j.issn.0412-4030.2018.03.013

摘要/Abstract

摘要： 目的检测5-羟甲基胞嘧啶（5?hmc）在黑素瘤组织中的表达水平，分析5?hmc与黑素瘤侵袭、转移、预后的相关性。方法采用免疫组化SP法检测5?hmc在67例黑素瘤、20例色素痣组织标本中的表达，采用Cox比例风险回归模型进行单因素和多因素回归分析5?hmc表达与黑素瘤患者预后的相关关系。结果黑素瘤中5?hmc表达阳性率为40.30%（27/67），色素痣为75%（15/20），两组间差异有统计学意义（χ2 = 7.428，P = 0.006）。美国癌症联合会临床分期Ⅳ期黑素瘤中5?hmc表达水平明显低于Ⅱ、Ⅲ期黑素瘤（χ2 = 4.416，P = 0.036），淋巴结转移患者5?hmc表达水平明显低于无淋巴结转移患者（χ2 = 5.902，P = 0.015），且5?hmc表达水平随黑素瘤组织Clark分级升高而降低（χ2 = 4.828，P = 0.028）。5?hmc表达水平在不同年龄、性别、民族黑素瘤患者之间分布差异无统计学意义（P > 0.05）。Cox回归模型多因素分析显示，存在远处淋巴结转移（风险比：2.67，95% CI：1.22 ~ 5.84）、未手术切除（风险比：0.41，95% CI：0.18 ~ 0.95）、5?hmc低水平表达（风险比：3.54，95% CI：1.09 ~ 11.43）为预后不良的独立影响因素。结论 5?hmc可能参与黑素瘤侵袭转移，与黑素瘤预后相关。

关键词: 5-甲基胞嘧啶, 痣和黑素瘤, 生物学标记, 预后, 肿瘤转移

Abstract: Wang Ying, Kang Xiaojing, ZhaoJuan, Liang Junqin, Zhang Dezhi, Chai Li, Wang Peng, Wang Weijia Department of Dermatology and Venereology, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China Corresponding author: Kang Xiaojing, Email: drkangxj666@163.com 【Abstract】 Objective To detect the level of 5-hydroxymethyl-cytosine（5-hmc）in melanoma tissues, and to analyze the correlation between 5-hmc and the invasion, metastasis and prognosis of melanoma. Methods A streptavidin-peroxidase immunohistochemical method was used to detect the level of 5-hmc in 67 melanoma tissues and 20 pigmented nevi tissues. Univariate and multivariate analyses were performed with the Cox′s proportional hazards regression model to analyze the correlation between the of 5-hmc and the prognosis of melanoma. Results The rate of 5-hmc was significantly lower in melanoma tissues than in pigmented nevus tissues （40.30%［27/67］ vs. 75%［15/20］, χ2 = 7.428, P = 0.006）. According to American Joint Committee on Cancer （AJCC） TNM staging system, the level of 5-hmc was significantly lower in the stage Ⅳmelanoma tissues than in the stage Ⅱ and stage Ⅲ melanoma tissues （χ2 = 4.416, P = 0.036）. Patients with lymph node metastasis showed significantly lower of 5-hmc compared with those without lymph node metastasis （χ2 = 5.902, P = 0.015）, and the level of 5-hmc significantly decreased along with the increase of Clark grade （χ2 = 4.828, P = 0.028）. There were no significant differences in the level of 5-hmc between patients of different ages, genders or nationalities （P > 0.05）. Multivariate Cox regression analysis showed that distant lymph node metastasis （HR: 2.67, 95% CI: 1.22 - 5.84）, not receiving surgical resection （HR: 0.41, 95% CI: 0.18 - 0.95）, and low of 5-hmc（HR: 3.54, 95% CI: 1.09 - 11.43）were independent risk factors for poor prognosis of melanoma. Conclusion 5-Hmc may participate in the invasion and metastasis of melanoma, and be associated with the prognosis of melanoma.

Key words: 5-Methylcytosine, Nevi and melanomas, Biological marker, Prognosis, Neoplasm metastasis

王莹康晓静赵娟梁俊琴张德志柴莉王鹏王唯嘉. 5-羟甲基胞嘧啶表达与黑素瘤侵袭、转移、预后的相关性分析[J]. 中华皮肤科杂志, 2018, 51(3): 214-217.

wang Zhang DeZhi Peng WANG Wei-Jia. Correlation analysis between the of 5-hydroxymethyl-cytosine and invasion, metastasis and prognosis of melanoma[J]. Chinese Journal of Dermatology, 2018, 51(3): 214-217.

参考文献 15

［1］	Xu Y, Wu F, Tan L, et al. Genome⁃wide regulation of 5hmC, 5mC, and gene by Tet1 hydroxylase in mouse embryonic stem cells［J］. Mol Cell, 2011,42（4）:451⁃464. doi: 10.1016/j.molcel.2011.04.005.<br />
［2］	Kriaucionis S, Heintz N. The nuclear DNA base 5⁃hydroxymethyl⁃cytosine is present in Purkinje neurons and the brain［J］. Science, 2009,324（5929）:929⁃930. doi: 10.1126/science.1169786.<br />
［3］	Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5⁃methylcyto⁃sine to 5⁃hydroxymethylcytosine in mammalian DNA by MLL partner TET1［J］. Science, 2009,324（5929）:930⁃935. doi: 10. 1126/science.1170116.<br />
［4］	Haffner MC, Chaux A, Meeker AK, et al. Global 5⁃hydroxymethyl⁃cytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers［J］. Oncotarget, 2011,2（8）:627⁃637. doi: 10.18632/oncotarget.316.<br />
［5］	Yang H, Liu Y, Bai F, et al. Tumor development is associated with decrease of TET gene and 5⁃methylcytosine hydroxy⁃lation［J］. Oncogene, 2013,32（5）:663⁃669. doi: 10.1038/onc. 2012.67.<br />
［6］	Gambichler T, Sand M, Skrygan M. Loss of 5⁃hydroxymethyl⁃cytosine and ten⁃eleven translocation 2 protein in malignant melanoma［J］. Melanoma Res, 2013,23（3）:218⁃220. doi: 10.1097/CMR.0b013e32835f9bd4.<br />
［7］	Lian CG, Xu Y, Ceol C, et al. Loss of 5⁃hydroxymethylcytosine is an epigenetic hallmark of melanoma［J］. Cell, 2012,150（6）:1135⁃1146. doi: 10.1016/j.cell.2012.07.033.<br />
［8］	Kudo Y, Tateishi K, Yamamoto K, et al. Loss of 5⁃hydroxymethyl⁃cytosine is accompanied with malignant cellular transformation［J］. Cancer Sci, 2012,103（4）:670⁃676. doi: 10.1111/j.1349⁃7006.2012.02213.x.<br />
［9］	Ko M, Huang Y, Jankowska AM, et al. Impaired hydroxylation of 5⁃methylcytosine in myeloid cancers with mutant TET2［J］. Nature, 2010, 468（7325）:839⁃843. doi: 10.1038/nature09586.<br />
［10］	Uchiyama R, Uhara H, Uchiyama A, et al. 5⁃Hydroxymethyl⁃cytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi［J］. J Dermatol Sci, 2014,73（2）:161⁃163. doi: 10.1016/j.jdermsci.2013.09.008.<br />
［11］	Larson AR, Dresser KA, Zhan Q, et al. Loss of 5⁃hydroxymethyl⁃cytosine correlates with increasing morphologic dysplasia in melanocytic tumors［J］. Mod Pathol, 2014,27（7）:936⁃944. doi: 10.1038/modpathol.2013.224.<br />
［12］	Lee JJ, Granter SR, Laga AC, et al. 5⁃Hydroxymethylcytosine in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies［J］. Mod Pathol, 2015,28（2）:218⁃229. doi: 10.1038/modpathol.2014.99.<br />
［13］	Rodic N, Zampella J, Sharma R, et al. Diagnostic utility of 5⁃hydroxymethylcytosine immunohistochemistry in melanocytic proliferations［J］. J Cutan Pathol, 2015,42（11）:807⁃814. doi: 10.1111/cup.12564.<br />
［14］	陈文静, 康晓静, 孙振柱, 等. 新疆地区96例维族恶性黑素瘤临床特征及预后分析［J］. 中国麻风皮肤病杂志, 2015,（5）:259⁃261, 264.<br />
［15］	曾颖, 康晓静, 张祥月, 等. 肢端型黑素瘤NRAS基因突变检测及预后分析［J］.中华皮肤科杂志, 2016,49（7）:474⁃477. doi: 10.3760/cma.j.issn.0412⁃4030.2016.07.006.<br />

[1]	马阳阳王平胡文婷徐永平张小燕黎钊虞闻仲朱蒙燕许爱娥. 泛素结合酶2S在恶性黑素瘤中的表达及其对黑素瘤细胞生物学行为的影响[J]. 中华皮肤科杂志, 2019, 52(8): 542-547.
[2]	平晓芳崔锡梅陈伟邢卫斌. 木犀草素对黑素瘤B16细胞系生长、转移及血管生成拟态形成的抑制作用研究[J]. 中华皮肤科杂志, 2019, 52(6): 401-407.
[3]	王志伟李伟人郑德义杜娇王毅柴磊刘莉韩庆玲. 皮肤Merkel细胞癌171例临床及病理回顾分析[J]. 中华皮肤科杂志, 2018, 51(9): 695-698.
[4]	吴飞陈佳诸允露刘业强. 内脏恶性肿瘤皮肤转移50例临床病理分析[J]. 中华皮肤科杂志, 2018, 51(12): 865-868.
[5]	鲁静浩周行刘超凡朱鹭冰李明. 皮肌炎皮疹与间质性肺病相关性的研究进展[J]. 中华皮肤科杂志, 2018, 51(10): 779-781.
[6]	曾颖康晓静张祥月靳颖柴莉曾明凤王莹王唯嘉. 肢端型黑素瘤NRAS基因突变检测及预后分析[J]. 中华皮肤科杂志, 2016, 49(7): 474-477.
[7]	林鹤李静王国庆孙金芳熊猛. 头皮血管肉瘤16例临床病理及治疗预后分析[J]. 中华皮肤科杂志, 2016, 49(3): 203-206.
[8]	王长松杨芒庄陈燕平印剑王平吕学霞. 皮下孤立性母细胞性浆细胞样树状突细胞肿瘤一例[J]. 中华皮肤科杂志, 2015, 48(4): 286-286.
[9]	范文葛宋琳毅张青松陶晓瑜张静王玲魏梅赵军. 恶性黑素瘤全身皮肤转移一例[J]. 中华皮肤科杂志, 2013, 46(9): 687-687.
[10]	彭洋李挺陈喜雪涂平杨勇刘伟李航. 恶性黑素瘤伴淋巴结转移一例诊疗过程分析[J]. 中华皮肤科杂志, 2013, 46(3): 199-201.
[11]	李雅妮王华庆邱立华钱正子张会来周世勇付凯郝希山. 原发性皮肤B细胞淋巴瘤26例临床特点及预后分析[J]. 中华皮肤科杂志, 2012, 45(7): 474-477.
[12]	徐教生李敏黄欣张永红周春菊薛学敏段泽君孙琳刘翠苓高子芬. 36例皮肤天然杀伤细胞/T细胞淋巴瘤临床病理学研究[J]. 中华皮肤科杂志, 2011, 44(9): 611-614.
[13]	曹宏田晓丰孙月芳刘士瑞李福秋. 卵巢癌皮肤转移一例[J]. 中华皮肤科杂志, 2011, 44(12): 850-850.
[14]	李凯陈柳青杨光艳邢建军宋玲娟罗庆白静峰张良曾宪玉周小勇段逸群. 182例红皮病病因与临床特征分析[J]. 中华皮肤科杂志, 2011, 44(11): 786-788.
[15]	高宇应斌宇郭蕾. 以皮肤损害为特征表现的创伤弧菌感染23例[J]. 中华皮肤科杂志, 2010, 43(6): 374-377.